BRIEF-Allergan says experimental anti-depressant would serve "huge" market

* Allergan CEO, in conference call with analysts, says company will remain more of a "virtual" research company, relying mainly on licensing deals or acquisitions
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.